Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Enobosarm

PLATEAU

Veru Inc · Phase 2 · Active, not recruiting · Enrollment 239

NCT07446998

ArmPopulationDoseWeeksEstimandWeight change
Subcutaneous injectable semaglutide and oral enobosarm 3mgObesity or overweight3mgn/rn/rn/r
Subcutaneous injectable semaglutide and oral PlaceboObesity or overweightn/rn/rn/rn/r